vaccine

Chennai: A Chennai volunteer who has sued Serum Institute of India (SII) for adverse reactions of the Oxford vaccine, is facing difficulty in doing simple tasks such as writing, and has lost his American job claims his wife. The Pune-based…

New Delhi: India may authorise the emergency use of a vaccine against coronavirus for the public by this month or early next month, according to a member of the national task force on COVID-19 management. “Hopeful that by the end of this…

Chennai: In a setback to the development of COVID-19 vaccines in India, a 40-year-old man has sent a legal notice to Serum Institute of India (SII) and others seeking Rs 5 crore in compensation, and also sought a halt to the ongoing…

Lucknow: The Uttar Pradesh government has launched a huge exercise to make space for COVID-19 vaccine as and when it arrives. Chief Minister Yogi Adityanath has instructed to prepare for a 1.23 lakh-litre cold chain storage capacity in the…

New Delhi: Schools in Delhi are unlikely to reopen till a vaccine to prevent coronavirus disease is available, Delhi Health Minister Satyendar Jain said on Thursday. “There are no plans to open the schools as of now. A vaccine is likely to…

London: Pharma major Pfizer on Wednesday reported that its COVID-19 vaccine is 95 per cent effective in phase 3 trials and would be applying for emergency US authorization within days. The vaccine, developed with German partner BioNTech…

New Delhi: Common people will have to wait till 2022 for a shot of the coronavirus vaccine, AIIMS Director Dr Randeep Guleria told CNN-News18 in an exclusive interview. He is a member of the national task force on the coronavirus…

Hyderabad: Bharat Biotech's vaccine Covaxin is expected to be launched in Q2 of 2021 pending approvals from authorities. The phase 3 trials will be started at the earliest across the nation, according to reports. Covaxin has been…

New Delhi: Two days after expressing "some preliminary good news" on the efficacy of Oxford vaccine candidate developed by the University of Oxford with AstraZeneca Plc, India's Serum Institute CEO Adar Poonawalla told NDTV on Wednesday…